Repligen Corp. (RGEN)
137.64
+2.24
(+1.65%)
USD |
NASDAQ |
Feb 24, 13:34
Repligen Price : 137.64 for Feb. 24, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Abbott Laboratories | 114.12 |
| Accuray, Inc. | 0.5738 |
| Alphatec Holdings, Inc. | 13.49 |
| Boston Scientific Corp. | 75.03 |
| Plus Therapeutics, Inc. | 0.2844 |
Price Related Metrics
| PE Ratio | 5334.88 |
| PS Ratio | 10.97 |
| Price to Book Value | 3.719 |
| Price to Free Cash Flow | 75.04 |
| Earnings Yield | 0.02% |
| Market Cap | 7.748B |
| Operating PE Ratio | 166.20 |
| Normalized PE Ratio | 229.21 |